SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:umu-106967"
 

Search: onr:"swepub:oai:DiVA.org:umu-106967" > Vascular endothelia...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Chien, Ming-Hsien (author)

Vascular endothelial growth factor-C (VEGF-C) promotes angiogenesis by induction of COX-2 in leukemic cells via the VEGF-R3/JNK/AP-1 pathway.

  • Article/chapterEnglish2009

Publisher, publication year, extent ...

  • 2009-10-13
  • Oxford University Press (OUP),2009
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:umu-106967
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-106967URI
  • https://doi.org/10.1093/carcin/bgp244DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Vascular endothelial growth factor (VEGF)-C is recognized as a tumor lymphangiogenic factor based on the effects of activated VEGF-R3 on lymphatic endothelial cells. Many tumor cells express VEGF-R3 but the function of this receptor in tumor cells is largely unknown. It has been reported that the VEGF-C/VEGF-R3 axis is activated in subsets of leukemia patients. Herein, we have shown that VEGF-C induces angiogenic activity in the tube formation assay invitro and Matrigel plug assay in vivo by upregulating an angiogenic factor, cyclooxygenase-2 (COX-2), through VEGF-R3 in the human acute myeloid leukemia (AML) cell line, THP-1. COX-2 induction by VEGF-C was also observed in other VEGF-R3(+) human AML cell lines (U937 and HL60). Moreover, immunohistochemical analysis of bone marrow specimens of 37 patients diagnosed with AML revealed that VEGF-C expression in specimens was associated with the expression of COX-2 (P < 0.001). The manner by which signaling pathways transduced by VEGF-C is responsible for COX-2 upregulation was further investigated. Blocking the p42/44 mitogen-activated protein kinase (MAPK) pathway with the MAPK kinase inhibitor, PD 98059, failed to inhibit VEGF-C-mediated COX-2 expression. However, VEGF-C-induced COX-2 upregulation was effectively abolished by overexpression of dominant-negative c-Jun N-terminal kinase (JNK) or treatment with the JNK inhibitor, SP 600125. VEGF-C induced JNK-dependent nuclear translocation of c-Jun. Furthermore, chromatin immunoprecipitation and reporter assays revealed that VEGF-C enhanced c-Jun binding to the cyclic adenosine 3',5'-monophosphate-response element of the COX-2 promoter and induced COX-2 expression. In sum, the data herein highlight the pathogenic role of VEGF-C in leukemia via regulation of angiogenesis through upregulation of COX-2.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Ku, Chia-Chi (author)
  • Johansson, GunnarUmeå universitet,Onkologi,Umeå University(Swepub:umu)gurjon98 (author)
  • Chen, Min-Wei (author)
  • Hsiao, Michael (author)
  • Su, Jen-Liang (author)
  • Inoue, Hiroyasu (author)
  • Hua, Kuo-Tai (author)
  • Wei, Lin-Hung (author)
  • Kuo, Min-Liang (author)
  • Umeå universitetOnkologi (creator_code:org_t)

Related titles

  • In:Carcinogenesis: Oxford University Press (OUP)30:12, s. 2005-130143-33341460-2180

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view